You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 10,092,542


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,092,542
Title:Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- soindoline-1,3-dione
Abstract: Stereomerically pure (+)-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoiso- indoline-1,3-dione, substantially free of its (-) isomer, and prodrugs, metabolites, polymorphs, salts, solvates, hydrates, and clathrates thereof are discussed. Also discussed are methods of using and pharmaceutical compositions comprising the (+) enantiomer of 2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoin- doline-1,3-dione are disclosed. The methods include methods of treating and/or preventing disorders ameliorated by the reduction of levels of TNF-.alpha. or the inhibition of PDE4.
Inventor(s): Muller; George W. (Rancho Santa Fe, CA), Schafer; Peter H. (Belle Mead, NJ), Man; Hon-Wah (Princeton, NJ), Ge; Chuansheng (Belle Mead, NJ)
Assignee: Celgene Corporation (Summit, NJ)
Application Number:15/629,678
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of United States Patent 10,092,542: Claims and Patent Landscape

Introduction

United States Patent 10,092,542, titled "Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione," involves a specific compound and its applications, particularly in the context of medical treatments. This analysis will delve into the claims of the patent, the legal and technical aspects, and the broader patent landscape to provide a comprehensive understanding.

Patent Overview

Compound and Structure

The patent focuses on the compound (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, which is described in detail along with its chemical structure and synthesis methods[1][3][5].

Claims

The patent includes multiple claims that cover various aspects of the compound, including its use, dosage forms, and therapeutic applications. Here are some key claim categories:

Therapeutic Uses

The claims outline the compound's use in treating various diseases and disorders, such as bone loss and other conditions related to inflammatory processes and diseases[1].

Dosage Forms

The patent specifies different dosage forms of the compound, including salts and other chemical classes, highlighting the versatility of the compound in pharmaceutical applications[1][3].

Synthesis and Isolation

Claims also cover the methods for synthesizing and isolating the compound from racemic mixtures, which is crucial for its purity and efficacy[1][3][5].

Legal Analysis

Patent Eligibility

The patent's eligibility under U.S. patent law, particularly 35 U.S.C. § 101, is a critical consideration. While this patent does not face the same issues as those related to abstract ideas or generic computer functions (as seen in the Federal Circuit's decision in AI Visualize, Inc. v. Nuance Communications, Inc.), it must still meet the criteria for patentability, including novelty, non-obviousness, and utility[2].

Prior Art and Novelty

The patent must demonstrate that the compound and its uses are novel and not obvious over prior art. The detailed description of the compound and its synthesis methods helps establish this novelty[1].

Technical Analysis

Chemical Properties

The compound's chemical properties, such as its ethoxy and methoxyphenyl groups, are crucial for its therapeutic effects. These properties are analyzed in detail to understand the compound's mechanism of action and its potential side effects[1][3].

Therapeutic Efficacy

The patent provides evidence of the compound's therapeutic efficacy, including its ability to prevent or reduce the progression of diseases like bone loss. This efficacy is supported by experimental data and clinical trials[1].

Patent Landscape Analysis

Geographic Focus

Understanding the geographic distribution of patent filings related to this compound can provide insights into the strategic focus of companies involved. For instance, if a company has a high prevalence of patent publications in specific jurisdictions, it may indicate significant research or manufacturing activities in those areas[4].

Competitor Analysis

A patent landscape analysis can reveal competitors and their focus areas. By identifying the top patent owners and their portfolio compositions, companies can gauge the level of competition and potential collaboration opportunities in the field[4].

Saturation Level

Assessing the saturation level of the patent space related to this compound helps in understanding the potential rewards and risks of entering this market. A highly saturated space may indicate that it is challenging to secure new patents, prompting a need to explore alternative technologies[4].

Strategic Insights

Research and Development

Companies considering investment in this area should conduct a comprehensive patent landscape analysis to identify gaps in the existing technology and potential areas for innovation. This analysis can guide R&D decisions and help in pivoting to newer, less saturated technology areas[4].

Licensing and Litigation

Understanding the patent landscape is crucial for licensing and litigation strategies. Companies can identify jurisdictions where they have a strong patent presence and where they might need to enforce their patents more aggressively[4].

Practice Tips

Specific Implementation

When drafting patent claims, it is essential to describe a concrete embodiment or specific implementation of the invention. Merely reciting an abstract idea or generic processes does not suffice; the claims must transform the abstract idea into a patent-eligible application[2].

Geographic Intelligence

Setting up current awareness alerts for patenting activity in critical research and manufacturing regions can provide ongoing strategic insights. This helps in monitoring competitors and identifying emerging trends in the industry[4].

Key Takeaways

  • Compound Specificity: The patent focuses on a specific compound with detailed descriptions of its structure, synthesis, and therapeutic uses.
  • Legal Compliance: The patent must comply with U.S. patent law, particularly in terms of novelty, non-obviousness, and utility.
  • Technical Efficacy: The compound's therapeutic efficacy is supported by experimental data and clinical trials.
  • Geographic and Competitive Analysis: Understanding the geographic distribution and competitor landscape is crucial for strategic decisions.
  • Saturation and Innovation: Assessing the patent space saturation helps in identifying areas for innovation and potential risks.

FAQs

Q: What is the primary compound described in United States Patent 10,092,542?

A: The primary compound is (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione.

Q: What are the main therapeutic uses of the compound?

A: The compound is used in treating diseases such as bone loss and other conditions related to inflammatory processes.

Q: How is the compound synthesized and isolated?

A: The patent describes methods for synthesizing the compound and isolating it from racemic mixtures.

Q: What is the importance of patent landscape analysis in this context?

A: Patent landscape analysis helps in understanding the competitive landscape, identifying gaps in existing technology, and making strategic R&D and licensing decisions.

Q: What are the key considerations for drafting patent claims in this area?

A: Claims must describe a concrete embodiment or specific implementation of the invention to ensure patent eligibility.

Sources

  1. US10092542B2 - Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione - Google Patents.
  2. Federal Circuit Affirms Dismissal of Patent Claims Directed to Visualization of Medical Scans as Ineligible Subject Matter Under 35 U.S.C. § 101 - Akin Gump.
  3. EP2223688B1 - (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione - European Patent Office.
  4. Patent Landscape Analysis - Uncovering Strategic Insights - AcclaimIP.
  5. CN101683334A - (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-mesyl - Google Patents.

More… ↓

⤷  Subscribe

Details for Patent 10,092,542

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Amgen Inc. PROLIA denosumab Injection 125320 June 01, 2010 ⤷  Subscribe 2022-03-20
Amgen Inc. XGEVA denosumab Injection 125320 November 18, 2010 ⤷  Subscribe 2022-03-20
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.